AB0496 Efficacy of Tofacitinib in Combination with Methotrexate Compared to Biological Disease Modifying Antirheumatic Drugs in Combination with Methotrexate in Rheumatoid Arthritis Patients with an Inadequate Response to Methotrexate: Overview of Systematic Review
BackgroundTofacitinib is an oral Janus kinase (JAK) inhibitor for the treatment of rheumatoid arthritis (RA). JAKs are intracellular enzymes which transmit signals that influence hematopoiesis and immune cell function through phosphorylate and activate the signal transducers and activators of transc...
Gespeichert in:
Veröffentlicht in: | Annals of the rheumatic diseases 2015-06, Vol.74 (Suppl 2), p.1064-1064 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!